Aquestive Therapeutics Inc - ESG Rating & Company Profile powered by AI
This ESG score covers seventeen United Nations SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Life on Land'. Comprehensive Sustainability analysis of Aquestive Therapeutics Inc can be accessed by registering for free. Check the end of the page for potential risks for Aquestive Therapeutics Inc based on sector, location and marketcap.
Aquestive Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 2.7, social score of 3.2 and governance score of 8.0.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 837 | Zentiva as | 4.7 | High |
| 837 | Zogenix Inc | 4.7 | High |
| 852 | Aquestive Therapeutics Inc | 4.6 | High |
| 852 | Canopy Growth Corp | 4.6 | High |
| 852 | Novavax Inc | 4.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aquestive Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aquestive Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Aquestive Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aquestive Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Aquestive Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aquestive Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aquestive Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Aquestive Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aquestive Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aquestive Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aquestive Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aquestive Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aquestive Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aquestive Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Aquestive Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Aquestive Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aquestive Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aquestive Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.